Announced Sat, 6 Sept · 17:58 IST

Notice of 08th AGM of the Company

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Dr Lalchandani Labs Ltd has issued the notice for its 8th AGM scheduled for Tuesday, September 30, 2025 at 3:00 PM in New Delhi. Seven resolutions are on the agenda, including routine items like adoption of FY25 audited financials and re-appointment of Managing Director Mr. Arjan Lalchandani (DIN: 07014579), who holds 26.56% of the company's shares. Other key items include the appointment of M/s. Chauhan Pradeep & Associates as Secretarial Auditors for a 5-year term (FY26 to FY30), re-appointment of Mr. Mohit Lalchandani as Whole Time Director for another 5 years at a remuneration of Rs. 14.40 lakh per annum, and appointment of Mr. Mohan Lal Gandhi (aged 70+) as Independent Director for 5 years. A notable resolution seeks to increase the authorised share capital from Rs. 4.5 crore (45 lakh equity shares) to Rs. 11 crore (1.10 crore equity shares), a jump of about 144%, along with a corresponding amendment to the Memorandum of Association. The record date/cut-off date for e-voting eligibility is September 23, 2025.

Likely market impact

The significant jump in authorised capital (from Rs. 4.5 Cr to Rs. 11 Cr) is the most material item and signals likely future fundraising, a stock split, bonus issue, or equity-based acquisitions, which could lead to share dilution later. The board remains promoter-family dominated with related-party appointments, which shareholders should weigh when voting.